Free Trial

Mannatech (MTEX) Competitors

Mannatech logo
$11.87 +0.43 (+3.76%)
(As of 12/20/2024 05:31 PM ET)

MTEX vs. PWUP, CTMX, RVPH, KPTI, ANL, QNCX, PMVP, ALXO, GNLX, and IKNA

Should you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include PowerUp Acquisition (PWUP), CytomX Therapeutics (CTMX), Reviva Pharmaceuticals (RVPH), Karyopharm Therapeutics (KPTI), Adlai Nortye (ANL), Quince Therapeutics (QNCX), PMV Pharmaceuticals (PMVP), ALX Oncology (ALXO), Genelux (GNLX), and Ikena Oncology (IKNA). These companies are all part of the "pharmaceutical products" industry.

Mannatech vs.

Mannatech (NASDAQ:MTEX) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk and media sentiment.

PowerUp Acquisition has a net margin of 0.00% compared to Mannatech's net margin of -1.26%. PowerUp Acquisition's return on equity of 0.00% beat Mannatech's return on equity.

Company Net Margins Return on Equity Return on Assets
Mannatech-1.26% -15.62% -3.76%
PowerUp Acquisition N/A N/A N/A

PowerUp Acquisition has lower revenue, but higher earnings than Mannatech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mannatech$121.55M0.18-$2.24M-$0.81-14.65
PowerUp AcquisitionN/AN/AN/AN/AN/A

13.0% of Mannatech shares are held by institutional investors. Comparatively, 19.2% of PowerUp Acquisition shares are held by institutional investors. 41.5% of Mannatech shares are held by company insiders. Comparatively, 48.0% of PowerUp Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Mannatech has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500.

In the previous week, Mannatech had 1 more articles in the media than PowerUp Acquisition. MarketBeat recorded 1 mentions for Mannatech and 0 mentions for PowerUp Acquisition. Mannatech's average media sentiment score of 0.00 equaled PowerUp Acquisition'saverage media sentiment score.

Company Overall Sentiment
Mannatech Neutral
PowerUp Acquisition Neutral

Mannatech received 310 more outperform votes than PowerUp Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
MannatechOutperform Votes
310
76.54%
Underperform Votes
95
23.46%
PowerUp AcquisitionN/AN/A

Summary

PowerUp Acquisition beats Mannatech on 5 of the 9 factors compared between the two stocks.

Get Mannatech News Delivered to You Automatically

Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MTEX vs. The Competition

MetricMannatechMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$22.38M$378.11M$5.14B$9.08B
Dividend YieldN/AN/A5.09%4.23%
P/E Ratio-14.6532.5989.9717.18
Price / Sales0.186.081,116.21116.99
Price / CashN/A10.6642.8937.86
Price / Book2.101.884.784.78
Net Income-$2.24M-$50.37M$120.23M$225.60M
7 Day Performance13.81%-3.56%-1.92%-1.23%
1 Month Performance36.75%-7.00%11.49%3.36%
1 Year Performance56.80%-6.41%30.57%16.60%

Mannatech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MTEX
Mannatech
0.2128 of 5 stars
$11.87
+3.8%
N/A+43.0%$22.38M$121.55M-14.65250Analyst Forecast
Gap Up
PWUP
PowerUp Acquisition
N/A$11.43
flat
N/A+5.7%$88.81MN/A0.00N/A
CTMX
CytomX Therapeutics
4.321 of 5 stars
$1.12
+0.9%
$5.77
+415.4%
-18.7%$87.65M$101.21M6.53170News Coverage
Positive News
RVPH
Reviva Pharmaceuticals
3.012 of 5 stars
$2.62
+0.4%
$15.50
+491.6%
-63.5%$87.61MN/A-2.355High Trading Volume
KPTI
Karyopharm Therapeutics
3.8015 of 5 stars
$0.69
-1.3%
$5.00
+623.5%
-16.2%$87.21M$148.44M-0.61380
ANL
Adlai Nortye
1.583 of 5 stars
$2.36
+3.1%
$9.00
+281.4%
-75.7%$87.08M$5M0.00127
QNCX
Quince Therapeutics
2.8954 of 5 stars
$1.90
-6.4%
$8.50
+347.4%
+60.4%$83.60MN/A-1.6460Analyst Forecast
Analyst Revision
News Coverage
PMVP
PMV Pharmaceuticals
1.7944 of 5 stars
$1.58
flat
$5.80
+267.1%
-34.5%$81.77MN/A0.0050Positive News
ALXO
ALX Oncology
3.192 of 5 stars
$1.55
+6.6%
$10.67
+590.4%
-87.7%$81.49MN/A-0.4940Analyst Forecast
News Coverage
Gap Up
GNLX
Genelux
0.8843 of 5 stars
$2.33
flat
$18.25
+683.3%
-82.9%$80.47M$8,000.00-2.4510
IKNA
Ikena Oncology
2.8725 of 5 stars
$1.64
-0.6%
$3.00
+82.9%
-20.5%$79.14M$659,000.00-1.3470

Related Companies and Tools


This page (NASDAQ:MTEX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners